Idioma: Inglés
Publicado por Springer Nature Switzerland AG, Cham, 2026
ISBN 10: 3032102766 ISBN 13: 9783032102768
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
EUR 64,72
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. This book provides a comprehensive exploration of how artificial intelligence (AI) is transforming every stage of drug discovery and developmentfrom the initial identification of drug targets to clinical trials and regulatory approval. The book delves into how AI is used to screen chemical compounds, predict toxicity, personalize treatment plans, and even discover new uses for existing drugs. Each chapter presents real-world case studies, current research trends, and the challenges of integrating AI into traditional drug pipelines, including data quality, ethical concerns, and regulatory hurdles. Written for researchers, students, healthcare professionals, and industry leaders, this book combines cutting-edge scientific insights with practical applications. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 53,60
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: Brand New. 9.45x6.61 inches. In Stock.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 81,31
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Springer Nature Switzerland AG, Cham, 2026
ISBN 10: 3032102766 ISBN 13: 9783032102768
Librería: CitiRetail, Stevenage, Reino Unido
EUR 55,39
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. This book provides a comprehensive exploration of how artificial intelligence (AI) is transforming every stage of drug discovery and developmentfrom the initial identification of drug targets to clinical trials and regulatory approval. The book delves into how AI is used to screen chemical compounds, predict toxicity, personalize treatment plans, and even discover new uses for existing drugs. Each chapter presents real-world case studies, current research trends, and the challenges of integrating AI into traditional drug pipelines, including data quality, ethical concerns, and regulatory hurdles. Written for researchers, students, healthcare professionals, and industry leaders, this book combines cutting-edge scientific insights with practical applications. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Idioma: Inglés
Publicado por Springer, Springer International Publishing, 2026
ISBN 10: 3032102766 ISBN 13: 9783032102768
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 53,49
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book provides a comprehensive exploration of how artificial intelligence (AI) is transforming every stage of drug discovery and development from the initial identification of drug targets to clinical trials and regulatory approval. The book delves into how AI is used to screen chemical compounds, predict toxicity, personalize treatment plans, and even discover new uses for existing drugs. Each chapter presents real-world case studies, current research trends, and the challenges of integrating AI into traditional drug pipelines, including data quality, ethical concerns, and regulatory hurdles. Written for researchers, students, healthcare professionals, and industry leaders, this book combines cutting-edge scientific insights with practical applications.
Idioma: Inglés
Publicado por Springer Nature Switzerland AG, Cham, 2026
ISBN 10: 3032102766 ISBN 13: 9783032102768
Librería: AussieBookSeller, Truganina, VIC, Australia
EUR 98,99
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. This book provides a comprehensive exploration of how artificial intelligence (AI) is transforming every stage of drug discovery and developmentfrom the initial identification of drug targets to clinical trials and regulatory approval. The book delves into how AI is used to screen chemical compounds, predict toxicity, personalize treatment plans, and even discover new uses for existing drugs. Each chapter presents real-world case studies, current research trends, and the challenges of integrating AI into traditional drug pipelines, including data quality, ethical concerns, and regulatory hurdles. Written for researchers, students, healthcare professionals, and industry leaders, this book combines cutting-edge scientific insights with practical applications. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Idioma: Inglés
Publicado por Springer, Berlin, Springer, 2026
ISBN 10: 3032102766 ISBN 13: 9783032102768
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 53,49
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book provides a comprehensive exploration of how artificial intelligence (AI) is transforming every stage of drug discovery and development from the initial identification of drug targets to clinical trials and regulatory approval. The book delves into how AI is used to screen chemical compounds, predict toxicity, personalize treatment plans, and even discover new uses for existing drugs. Each chapter presents real-world case studies, current research trends, and the challenges of integrating AI into traditional drug pipelines, including data quality, ethical concerns, and regulatory hurdles. Written for researchers, students, healthcare professionals, and industry leaders, this book combines cutting-edge scientific insights with practical applications. 150 pp. Englisch.
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 74,55
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND.
Librería: Majestic Books, Hounslow, Reino Unido
EUR 79,75
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand.
Idioma: Inglés
Publicado por Springer, Springer Jan 2026, 2026
ISBN 10: 3032102766 ISBN 13: 9783032102768
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 53,49
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book provides a comprehensive exploration of how artificial intelligence (AI) is transforming every stage of drug discovery and developmentfrom the initial identification of drug targets to clinical trials and regulatory approval. The book delves into how AI is used to screen chemical compounds, predict toxicity, personalize treatment plans, and even discover new uses for existing drugs. Each chapter presents real-world case studies, current research trends, and the challenges of integrating AI into traditional drug pipelines, including data quality, ethical concerns, and regulatory hurdles. Written for researchers, students, healthcare professionals, and industry leaders, this book combines cutting-edge scientific insights with practical applications.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 164 pp. Englisch.
Librería: preigu, Osnabrück, Alemania
EUR 50,25
Cantidad disponible: 5 disponibles
Añadir al carritoBuch. Condición: Neu. Artificial Intelligence in Drug Discovery and Development | Khalid Shaikh (u. a.) | Buch | Synthesis Lectures on Engineering, Science, and Technology | xiii | Englisch | 2026 | Springer | EAN 9783032102768 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.